Ross E. McKinney

9.2k total citations · 1 hit paper
121 papers, 3.8k citations indexed

About

Ross E. McKinney is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ross E. McKinney has authored 121 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Infectious Diseases, 37 papers in Virology and 12 papers in Epidemiology. Recurrent topics in Ross E. McKinney's work include HIV/AIDS Research and Interventions (38 papers), HIV Research and Treatment (36 papers) and HIV/AIDS drug development and treatment (34 papers). Ross E. McKinney is often cited by papers focused on HIV/AIDS Research and Interventions (38 papers), HIV Research and Treatment (36 papers) and HIV/AIDS drug development and treatment (34 papers). Ross E. McKinney collaborates with scholars based in United States, United Kingdom and Puerto Rico. Ross E. McKinney's co-authors include Catherine M. Wilfert, Samuel L. Katz, Daniel K. Benjamin, Randall G. Fisher, B.L. Clarke, Beatrice J. Edwards, Susan L. Greenspan, Ghada El‐Hajj Fuleihan, Matthew T. Drake and Murray J. Favus and has published in prestigious journals such as New England Journal of Medicine, JAMA and The Journal of Experimental Medicine.

In The Last Decade

Ross E. McKinney

115 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

2015 444 citations Ross E. McKinney et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross E. McKinney United States	33	1.3k	874	736	637	452	121	3.8k
Timothy J. Bush United States	28	940 0.7×	574 0.7×	1.2k 1.6×	70 0.1×	220 0.5×	37	2.6k
Philip C. Johnson United States	29	2.6k 2.0×	681 0.8×	1.9k 2.6×	58 0.1×	145 0.3×	109	4.6k
Marianne Harris Canada	33	2.3k 1.7×	1.7k 1.9×	659 0.9×	43 0.1×	153 0.3×	139	4.8k
Warren Winkelstein United States	38	1.7k 1.3×	918 1.1×	1.8k 2.4×	17 0.0×	369 0.8×	127	5.3k
Cristina Mussini Italy	29	1.8k 1.4×	1.1k 1.3×	1.1k 1.5×	27 0.0×	116 0.3×	160	3.6k
Chin‐Fu Hsiao Taiwan	36	683 0.5×	98 0.1×	852 1.2×	56 0.1×	583 1.3×	148	3.8k
Tom D. Thacher United States	34	296 0.2×	97 0.1×	553 0.8×	792 1.2×	196 0.4×	131	4.2k
Emmanuel A. Burdmann Brazil	44	264 0.2×	270 0.3×	487 0.7×	28 0.0×	197 0.4×	181	7.1k
Georgios K. Nikolopoulos Greece	38	1.4k 1.0×	420 0.5×	2.0k 2.7×	20 0.0×	213 0.5×	212	4.9k
Nicolai Lohse Denmark	24	903 0.7×	526 0.6×	829 1.1×	16 0.0×	105 0.2×	68	3.4k

Countries citing papers authored by Ross E. McKinney

Since Specialization

Citations

This map shows the geographic impact of Ross E. McKinney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross E. McKinney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross E. McKinney more than expected).

Fields of papers citing papers by Ross E. McKinney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross E. McKinney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross E. McKinney. The network helps show where Ross E. McKinney may publish in the future.

Co-authorship network of co-authors of Ross E. McKinney

This figure shows the co-authorship network connecting the top 25 collaborators of Ross E. McKinney. A scholar is included among the top collaborators of Ross E. McKinney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross E. McKinney. Ross E. McKinney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yin, Dwight E., Stephen R. Cole, Christina Ludema, et al.. (2023). A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children. American Journal of Epidemiology. 192(6). 916–928. 2 indexed citations

Fong, Youyi, Maria Dennis, Joshua Eudailey, et al.. (2021). Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus. The Journal of Infectious Diseases. 225(10). 1731–1740. 6 indexed citations

Yin, Dwight E., Christina Ludema, Stephen R. Cole, et al.. (2020). Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. PLoS ONE. 15(11). e0242405–e0242405. 2 indexed citations

Flores, Dalmacio Dennis, Ross E. McKinney, Joyell Arscott, & Julie Barroso. (2017). Obtaining waivers of parental consent: A strategy endorsed by gay, bisexual, and queer adolescent males for health prevention research. Nursing Outlook. 66(2). 138–148. 24 indexed citations

Harrison, Linda, Ann J. Melvin, Susan A. Fiscus, et al.. (2015). HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds. JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(1). 42–53. 7 indexed citations

Lichter, Allen S. & Ross E. McKinney. (2012). Toward a Harmonized and Centralized Conflict of Interest Disclosure. JAMA. 308(20). 2093–2093. 12 indexed citations

Castro, Hannah, Alexandra Compagnucci, Carlo Giaquinto, et al.. (2011). First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. The Lancet Infectious Diseases. 11(4). 273–283. 101 indexed citations

Englund, Janet A., Claire Raskino, Cindy Vavro, et al.. (2004). Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors. The Pediatric Infectious Disease Journal. 23(1). 15–22. 6 indexed citations

McKinney, Ross E. & Coleen K. Cunningham. (2004). Newer treatments for HIV in children. Current Opinion in Pediatrics. 16(1). 76–79. 7 indexed citations

10.

Benjamin, Danny, et al.. (2004). Growth Patterns Reflect Response to Antiretroviral Therapy in HIV-Positive Infants: Potential Utility in Resource-Poor Settings. AIDS Patient Care and STDs. 18(1). 35–43. 7 indexed citations

11.

Benjamin, Daniel K., Steven Hirschfeld, Coleen K. Cunningham, & Ross E. McKinney. (2004). Growth as a part of the composite endpoint in paediatric antiretroviral clinical trials. Journal of Antimicrobial Chemotherapy. 54(4). 701–703. 5 indexed citations

12.

Fisher, Randall G., Savithri Nageswaran, Megan Valentine, & Ross E. McKinney. (2001). Successful Prophylaxis Against Pneumocystis carinii Pneumonia in HIV-Infected Children Using Smaller Than Recommended Dosages of Trimethoprim-Sulfamethoxazole. AIDS Patient Care and STDs. 15(5). 263–269. 5 indexed citations

13.

Wang, Yi, Elizabeth Livingston, Ross E. McKinney, et al.. (1999). Pharmacokinetics of Didanosine in Antepartum and Postpartum Human Immunodeficiency Virus–Infected Pregnant Women and Their Neonates:An AIDS Clinical Trials Group Study. The Journal of Infectious Diseases. 180(5). 1536–1541. 33 indexed citations

14.

Fisher, Randall G., et al.. (1999). Candidal Mycetoma in the Neonatal Kidney. PEDIATRICS. 104(5). 1126–1129. 35 indexed citations

15.

Kline, Mark W., Russell B. Van Dyke, Jane C. Lindsey, et al.. (1998). A Randomized Comparative Trial of Stavudine (d4T) Versus Zidovudine (ZDV, AZT) in Children With Human Immunodeficiency Virus Infection. PEDIATRICS. 101(2). 214–220. 40 indexed citations

16.

Englund, Janet A., Carol J. Baker, Claire Raskino, et al.. (1996). Clinical and Laboratory Characteristics of a Large Cohort of Symptomatic, Human Immunodeficiency Virus-infected Infants and Children. The Pediatric Infectious Disease Journal. 15(11). 1025–1036. 50 indexed citations

17.

McKinney, Ross E. & Catherine M. Wilfert. (1994). Growth as a prognostic indicator in children with human immunodeficiency virus infection treated with zidovudine☆☆☆★★★♢. The Journal of Pediatrics. 125(5). 728–733. 19 indexed citations

18.

McKinney, Ross E.. (1991). Antiviral Therapy for Human Immunodeficiency Virus Infection in Children. Pediatric Clinics of North America. 38(1). 133–151. 3 indexed citations

19.

McKinney, Ross E., Mary Maha, Edward M. Connor, et al.. (1991). A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease. New England Journal of Medicine. 324(15). 1018–1025. 156 indexed citations

20.

McKinney, Ross E., Philip A. Pizzo, Gwendolyn B. Scott, et al.. (1990). Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. The Journal of Pediatrics. 116(4). 640–647. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact